On June 18–19, China Veterinary Drug Conference and Exhibition 2026 was held at the Hefei Binhu International Convention and Exhibition Center. Anhui Liberty Pharmaceutical Co., Ltd., a wholly‑owned subsidiary of Leadsynbio, joined the provincial delegationas a representative of outstanding animal health enterprises from Anhui, engaging with industry peers to explore new dynamics in the sector.
[ Details ]Jun 22,2026
From June 16 to 18, Leadsynbio made a strong impression atCPHI China 2026, showcasing a range of synthetic biology achievements and its internationally competitive product portfolio, while engaging with industry peers to explore future trends and partnership opportunities.
[ Details ]Jun 18,2026
Recently, Leadsynbio has been honored withsecond prize of the Hunan Provincial Science and Technology Progress Award. The award-winning project’s achievements were selected as a landmark product in the 2026 Hunan Provincial Future IndustryInnovation and Development Excellent Typical Cases, gaining dual provincial authoritative recognition.
[ Details ]Jun 01,2026
On May 14th, Lesdsynbio was invited to attend the Suzhou Biomanufacturing Industry Development Conference and was awarded the title of "Key Nurturing Enterprise in Biomanufacturing" in Suzhou.
[ Details ]May 19,2026
From May 12th to 14th, Leadsynbio's animal nutrition division made its debut at FENAGRA 2026 in Brazil, the largest and most influential animal nutrition and feed industry exhibition in Latin America.
[ Details ]May 19,2026
On April 18th, the China Feed Industry Expo 2026 grandly opened in Nanchang, Jiangxi Province. As an innovative enterprise in the global animal nutrition field, Leadsynbio made a significant appearance with its core animal nutrition products and new productplans, exploring cutting-edge trends and innovative technologies with industry experts and global customers.
[ Details ]Apr 21,2026
On April 17th, Leadsynbio held an animal nutrition distributor meeting themed "Synthetic Biology, Win-Win Future" in Nanchang, Jiangxi. Partners from all over the country gathered to discuss how synthetic biology can open up new growth opportunities forthe animal nutrition industry, deepen mutual trust, and look forward to a win-win future.
[ Details ]Apr 21,2026
On February 5th, Hunan LeadsynbioTechnology Co.,Ltd., a wholly-owned subsidiary of Suzhou LeadsynbioTechnologyCo.,Ltd., successfully passed the rigorous review and wonthe title of "National Green Factory" due to its outstandingperformance in green manufacturing.
[ Details ]Feb 11,2026
Suzhou Leadsynbio Technology Co.,Ltd. is honored to be recognized inthe Hurun Future Unicorns – China Cheetahs Index 2025. This prestigious list spotlights our continued commitment to innovation and excellent commercialization capabilities.
[ Details ]Feb 09,2026
Leveragingcutting-edge innovation and outstanding commercialization capabilities in the field of synthetic biology, Leadsynbio was successfully selectedfor the 2025 China Potential Unicorn Enterprises list, demonstrating ourstrong growthpotentialand core competitiveness.
[ Details ]Dec 17,2025
On June 18–19, China Veterinary Drug Conference and Exhibition 2026 was held at the Hefei Binhu International Convention and Exhibition Center. Anhui Liberty Pharmaceutical Co., Ltd., a wholly‑owned subsidiary of Leadsynbio, joined the provincial delegationas a representative of outstanding animal health enterprises from Anhui, engaging with industry peers to explore new dynamics in the sector.
sales@leadsynbio.com 
+86-0512-6285-2962 
3F-5F, Building C11, BioPark, 218 Xinghu St., Suzhou Industrial Park, Suzhou, Jiangsu, China 
